Showing 1 - 11 results of 11 for search '"Eye disease"', query time: 0.06s Refine Results
  1. 1
  2. 2

    Assessment of Knowledge and Practice of Various Eye Diseases in Sulaimani: A Descriptive Study by Abdulrahman M. Ibrahem, Salah Q. Mahmood, Muhammed Babakir-Mina, Salar Ibrahim Ali, Bakhtyar Kamal Talabany

    Published 2018-07-01
    “…Knowledge and practice of public, especially patients about eye diseases are important to reduce magnitude of human blindness. …”
    Get full text
    Article
  3. 3

    Association of arterial stiffness and eye disease: a systematic review and meta-analysis by Robert Scragg, Angela L Beros, John D Sluyter

    Published 2025-01-01
    “…We assessed the certainty of evidence using Grading of Recommendations, Assessment, Development and Evaluation.Results The systematic review of 61 studies (six for AMD, ten for glaucoma, six for RVO and 39 for retinopathy) showed that arterial stiffness overall was higher in people with eye disease than people without eye disease. Forty-four cross-sectional and case-control studies were included in the meta-analysis. …”
    Get full text
    Article
  4. 4

    Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage. by Nehal Nailesh Mehta, Ines D Nagel, Akshay Agnihotri, Anna Heinke, Lingyun Cheng, Dirk-Uwe Bartsch, William R Freeman, Maria-Laura Gomez

    Published 2025-01-01
    “…<h4>Purpose</h4>To determine the impact of severity of age-related macular degeneration (AMD) on subjective treatment response in patients treated for dry eye disease.<h4>Methods</h4>A total of 203 eyes diagnosed with evaporative dry eye disease (DED) due to meibomian gland dysfunction were treated using the LipiFlow or MiBoFlo systems. …”
    Get full text
    Article
  5. 5
  6. 6

    Saunders Ophthalmology Word Book / by Adams, Joyce

    Published 1991
    Subjects:
    View in OPAC
    Book
  7. 7
  8. 8

    Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial by Yue Zhao, Guang Yang, Yun-Qiong Lu, Mei-Yan Li, Jue Hong, Yan-Ting Yang, Xue-Jun Wang, Xie-He Kong, Zhao Ma, Xin-Yun Huang, Yue-Lan Zou, Xing-Tao Zhou, Xiao-Peng Ma

    Published 2023-12-01
    “…The secondary outcomes include tear meniscus height, the Schirmer I test, corneal and conjunctival sensation, the ocular surface disease index, corneal fluorescein staining, the numerical rating scale and the Chinese DE-related quality of life scale.Ethics and dissemination The trial protocol and informed consent were approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine (identifier: 2021–119), Shanghai Eye Disease Prevention and Treatment Center (identifier: 2022SQ003) and Eye and ENT Hospital of Fudan University (identifier: 2022014).Trial registration number NCT05552820.…”
    Get full text
    Article
  9. 9
  10. 10

    Bioassay-guided isolation and identification of antimutagenic compounds from Morina coulteriana and evaluation of its therapeutic potential by Jasbir Kour, Bashir Ahmad Lone, Amit Kumar, Bashir A. Ganai, Govind Yadav, Prasoon Gupta, Md.Niamat Ali, Seema Akbar

    Published 2025-02-01
    “…The plant Morina coulteriana has been traditionally used to cure eye diseases. Nevertheless, it has been explored for the first time for its antimutagenic/antigenotoxic potential and phytochemical profile. …”
    Get full text
    Article
  11. 11

    Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbu... by Dunming Xiao, Junling Weng, Lei Zhang, Chang Xing, Yan Wei, Yingyao Chen

    Published 2025-01-01
    “…<h4>Results</h4>In clinical output, IDegLira could reduce the cumulative incidence of various chronic complications in patients compared to the combined regimen. The eye diseases (background, proliferative retinopathy, macular edema, and visual loss) decreased by 24.4%, 41.1%, 18.9%, and 12.2%, respectively. …”
    Get full text
    Article